Impact of obesity in asthma: Possible future therapies

被引:11
|
作者
Tashiro, Hiroki [1 ,2 ]
Kurihara, Yuki [1 ]
Kuwahara, Yuki [1 ]
Takahashi, Koichiro [1 ]
机构
[1] Saga Univ, Fac Med, Dept Internal Med, Div Hematol Resp Med & Oncol, Saga, Japan
[2] Saga Univ, Fac Med, Dept Internal Med, Div Hematol Resp Med & Oncol, 5-1-1 Nabeshima, Saga, Saga 8498501, Japan
关键词
Asthma; Asthma therapy; Microbiome; Obesity; Pathophysiology; BODY-MASS INDEX; ALLERGIC AIRWAY DISEASE; INNATE LYMPHOID-CELLS; ACUTE OZONE EXPOSURE; CHAIN FATTY-ACIDS; QUALITY-OF-LIFE; WEIGHT-LOSS; GUT MICROBIOME; BARIATRIC SURGERY; PULMONARY RESPONSES;
D O I
10.1016/j.alit.2023.08.007
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Obesity is one of the factors associated with the severity of asthma. Obesity is associated with aggravation of the pathophysiology of asthma, including exacerbations, airway inflammation, decreased pulmonary function, and airway hyperresponsiveness. The present review addresses the characteristics of asthma with obesity, focusing especially on the heterogeneity caused by the degree of type 2 inflammation, sex differences, the onset of asthma, and race differences. To understand the severity mechanisms in asthma and obesity, such as corticosteroid resistance, fatty acids, gut micro biome, and cytokines, several basic research studies are evaluated. Finally, possible future therapies, including weight reduction, microbiome-targeted therapies, and other molecular targeted therapies are addressed. We believe that the present review will contribute to better understanding of the severity mechanisms and the establishment of novel treatments for severe asthma patients with obesity. (c) 2023 Japanese Society of Allergology. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
引用
收藏
页码:48 / 57
页数:10
相关论文
共 50 条
  • [42] Interleukin 23 and autoimmune diseases: current and possible future therapies
    Abdo, Ahmad Ismail Khaled
    Tye, Gee Jun
    INFLAMMATION RESEARCH, 2020, 69 (05) : 463 - 480
  • [43] Cannabinoid system in the skin - a possible target for future therapies in dermatology
    Kupczyk, Piotr
    Reich, Adam
    Szepietowski, Jacek C.
    EXPERIMENTAL DERMATOLOGY, 2009, 18 (08) : 669 - 679
  • [44] Interleukin 23 and autoimmune diseases: current and possible future therapies
    Ahmad Ismail Khaled Abdo
    Gee Jun Tye
    Inflammation Research, 2020, 69 : 463 - 480
  • [45] PTPIP51-A POSSIBLE TARGET FOR NOVEL DIABETES AND OBESITY THERAPIES
    Bobrich, M. A.
    Schwabe, S. A.
    Kamm, M.
    Brobeil, A. M.
    Krueger, K.
    Mooren, F. C.
    Steger, K.
    Tag, C.
    Wimmer, M.
    NUCLEIC ACID THERAPEUTICS, 2011, 21 (05) : A3 - A3
  • [46] The impact of obesity in patients with severe asthma in the Wessex Severe Asthma Cohort (WSAC)
    Fox, Lauren
    Brown, Thomas
    Wiffen, Laura
    Jones, Thomas
    Gove, Kerry
    Barber, Clair
    Elliott, Scott
    Rupani, Hitasha
    Chauhan, Anoop
    Howarth, Peter
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [47] Molecular mechanisms and clinical impact of biologic therapies in severe asthma
    Tashiro, Hiroki
    Kuwahara, Yuki
    Kurihara, Yuki
    Takahashi, Koichiro
    RESPIRATORY INVESTIGATION, 2025, 63 (01) : 50 - 60
  • [48] Impact of biological therapies in lung function in patients with severe asthma
    Menendez-Lobo, A.
    Rojo-Tolosa, S.
    Sanchez-Martinez, J. A.
    Perez-Ramirez, C.
    Jimenez-Galvez, G.
    Jimenez-Morales, A.
    Morales-Garcia, C.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [49] Impact of Smoking and Rhinitis on Response to Therapies in Patients with Asthma.
    Price, D.
    Sims, E.
    Kemp, L.
    von Ziegenweidt, J.
    Fan, T.
    Lee, A. J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
  • [50] Impact of pediatric obesity on acute asthma exacerbation in Japan
    Okubo, Yusuke
    Michihata, Nobuaki
    Yoshida, Koichi
    Morisaki, Naho
    Matsui, Hiroki
    Fushimi, Kiyohide
    Yasunaga, Hideo
    PEDIATRIC ALLERGY AND IMMUNOLOGY, 2017, 28 (08) : 763 - 767